Lexeo Therapeutics, Inc. Common Stock (LXEO) key performance indicators and operating metrics (1 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Premature Ventricular Contractions Reduction Post Six-Month Evaluation | 67.00 percent | FY2025-Q1 |
Back to LXEO overview · LXEO earnings · LXEO holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.